Minnesota-based Pops! Diabetes Care, which is working on a digital device and diabetes management platform, has raised a little over $1.2 million to bring its product to market. MedCity News confirmed the funding with Pops! CEO and cofounder Lonny Stormo, who previously served in executive roles at Medtronic. Last year, the company raised $500,000 from Minneapolis accelerator TreeHouse Health.
The Pops! system consists of an integrated blood glucose meter affixed to the back of a user’s smartphone and a Bluetooth-connected companion app. The meter uses stationary lancet and a one-step process to get a reading. The app is also supported by a SaaS component that allows the user’s physician, family members or anyone else involved in their day-to-day diabetes management to visualize the user’s glucose readings and medication information.
The goal is to make it faster, more discreet and less painful that other testing devices.
“Too many diabetics are experiencing multiple complications as a result of poor glucose control,” Stormo said in a statement at the time of the earlier funding round. “Our investors are enabling a major change through empowering patients to better self-manage their condition and create a new type of engagement from their support.”
The device is not yet FDA approved, but Stormo told MedCity the company plans to submit an application for 510(k) clearance later this year.
Pops! is also currently collaborating with the Children’s Hospitals and Clinics of Minnesota to accelerate development of the device.